Nevertheless, studies evaluating the putative tumor suppressive biological and clinical impact of NDRG2 were irrespective of intrinsic breast cancer subtypes or mainly focused on luminal or basal B breast cancer cell models in vitro and in vivo. This evidence concerns the gene NDRG2 and breast cancer.